Valuation

P/E--
P/B--
P/S--
EV/EBIT-6.8

Business Strength

ROE-18.5%
ROCE-12.8%
OPM-285.3%
NPM-285.3%

Growth (3Y CAGR)

EPS-76.5%
Sales--
Profit--
3Y Return+21.0%

Balance Sheet

Debt/Equity1.8
Debt8.54 Cr
Pledge0.0%
CWIP/Fixed Asset0.0%

Cash Position

CFO/NP--
FCF--
FCF 3Y Avg--
Cash/MCap2.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle700.8 days
Tradeable Free Float5.4%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
Return
-4.0%
+12.0%
+21.0%
--
--
Accelerating
Sales
-31.0%
--
--
--
--
--
Profit
--
--
--
--
-77.0%
--
ROE
--
--
+43.0%
--
--
--

Quarterly Results

Jun 2026

12 Aug
Rev
0 Cr
----
OPM--
NPM--
PAT
+11% YoY-1 Cr
EPS
---0.4

Mar 2026

26 May
Rev
1 Cr
----
OPM13.3%
NPM13.3%
PAT
+112% YoY0 Cr
EPS
+112% YoY0.1

Dec 2025

14 Feb
Rev
0 Cr
----
OPM--
NPM--
PAT
-139% YoY-1 Cr
EPS
-135% YoY-0.5

Sep 2025

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
-1129% YoY-1 Cr
EPS
-1100% YoY-0.6

Jun 2025

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
---1 Cr
EPS
---0.5

Mar 2025

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
-108% YoY-1 Cr
EPS
-108% YoY-0.6

Dec 2024

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
---0 Cr
EPS
---0.2

Sep 2024

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
---0 Cr
EPS
---0.1

Mar 2024

Rev
0 Cr
----
OPM--
NPM--
PAT
--11 Cr
EPS
--7.9

Dec 2023

PDF
Rev
0 Cr
----
OPM--
NPM--
PAT
--0 Cr
EPS
--0.0

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity1.75
Interest Coverage--x
Promoter Pledge0.0%
Borrowings9 Cr

Efficiency

Receivable Days700.8 days
Inventory Days days
Payable Days days
Cash Conversion cycle700.8 days

Cash Position

Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Free Cash Flow--

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Mar 2024
Dec 2023PDF ↗
Sales0100000000
Expenses1111110010
Operating Profit-10-1-1-1-1-0-0-10
OPM %--13.3%----------------
Other Income00000000120
Interest0000000000
Depreciation0000000000
Profit Before Tax-10-1-1-1-1-0-0110
Tax %0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%--
Net Profit-10-1-1-1-1-0-0110
Exceptional Items--------------------
EPS (Rs)-0.40.1-0.5-0.6-0.5-0.6-0.2-0.17.90.0
Sales Growth (YoY)--------------------
Sales Growth (QoQ)--------------------
OP Growth (YoY)12.7%111.6%-139.3%-1128.6%---59.3%--------
OP Growth (QoQ)-720.0%114.9%22.1%-21.1%17.4%-207.1%-300.0%------
Profit Growth (YoY)11.3%111.6%-139.3%-1128.6%---107.6%--------
EPS Growth (YoY)--111.7%-135.0%-1100.0%---107.6%--------
EPS Growth (QoQ)--114.9%21.7%-20.0%16.7%-200.0%-300.0%-100.6%----
OP Margin--13.3%----------------
Net Margin--13.3%----------------
Material Cost %--------------------
Employee Cost %--53.3%----------------
P/S--------------------
P/E--------------------
P/B--------------------

Shareholding Pattern

Shareholders:10.4K (+1.5%)
Current MixMar 2026

Annual Reports

12

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

Credit Ratings

6
crisilRating update
27 Nov 2025Report
careRating update
15 Nov 2024Report
crisilRating update
30 Sept 2024Report
careRating update
26 Oct 2023Report
crisilRating update
31 Jul 2023Report
careRating update